ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,083.57
      0.36%
      US Tech 100
      21,171.60
      -0.06%
      Dow Jones
      44,747.63
      -0.28%
      Brent Oil
      74.57
      0.55%
      Bitcoin
      97,609.21
      1.07%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Clinuvel Pharmaceuticals Limited (CUV) Quote

      Clinuvel Pharmaceuticals Limited

      Clinuvel Pharmaceuticals Limited (CUV)

      CUV Ventures Corp
      11.45
      -0.12
      (-1.04%)
      Closed February 07 12:00AM
      Delayed by 20 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      11.45
      Bid
      11.45
      Ask
      11.47
      Volume
      76,528
      11.45 Day's Range 11.70
      11.16 52 Week Range 17.71
      Market Cap
      573.688M
      Previous Close
      11.57
      Open
      11.60
      Last Trade
      4996
      @
      11.47
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      114,547
      Shares Outstanding
      50,103,765
      Dividend Yield
      -
      PE Ratio
      16.10
      Earnings Per Share (EPS)
      0.71
      Revenue
      88.74M
      Net Profit
      35.64M

      About Clinuvel Pharmaceuticals Limited

      Sector
      Medicinal Chems,botanicl Pds
      Industry
      Drugs-health R&d/testing Labs
      Website
      www.clinuvel.com
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      2000
      Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD11.57. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 11.16 to AUD 17.71.

      Clinuvel Pharmaceuticals currently has 50,103,765 shares outstanding. The market capitalization of Clinuvel Pharmaceuticals is AUD579.70 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 16.10.

      Ask ADVFN Intelligence (AI)

      CUV Latest News

      More News

      Europe Approves Novel Australian Drug Developed for Rare Sun Disease

      The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA...

      October 24 2014
      Business Wire

      Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

      Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

      November 11 2013
      PR Newswire (US)

      Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class...

      February 06 2012
      Business Wire

      Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise on the interaction of light and human skin...

      November 03 2011
      Business Wire

      EMA acknowledges Clinuvel’s novel drug filing in Europe in 2011

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it held a constructive Pre-Submission Meeting with the European Medicines Agency...

      May 12 2011
      Business Wire

      Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers'

      A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to...

      July 13 2010
      Business Wire

      Clinuvel Unveils SCENESSE® Following European Brand Approval

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that the European Medicines Agency (EMA) Name Review Group (NRG) and the Agency’s...

      May 18 2010
      Business Wire

      Preliminary Results in Clinuvel’s Phase III Porphyria Trial

      Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has obtained promising 4-months results in testing afamelanotide in a multicentre...

      December 21 2009
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.58-4.82128013312.0312.4911.3710009011.76103077DE
      4-0.35-2.9661016949211.812.4911.1610993911.72281142DE
      12-2.25-16.423357664213.714.0511.1611454712.28474203DE
      26-2.32-16.848220769813.7715.9911.169690813.28013068DE
      52-4.29-27.255400254115.7417.7111.1610191514.13363652DE
      156-11.4-49.890590809622.8528.7211.1610010917.07023213DE
      260-13.91-54.850157728725.3644.6711.1612085121.13683877DE

      CUV - Frequently Asked Questions (FAQ)

      What is the current Clinuvel Pharmaceuticals share price?
      The current share price of Clinuvel Pharmaceuticals is AUD 11.45
      How many Clinuvel Pharmaceuticals shares are in issue?
      Clinuvel Pharmaceuticals has 50,103,765 shares in issue
      What is the market cap of Clinuvel Pharmaceuticals?
      The market capitalisation of Clinuvel Pharmaceuticals is AUD 579.7M
      What is the 1 year trading range for Clinuvel Pharmaceuticals share price?
      Clinuvel Pharmaceuticals has traded in the range of AUD 11.16 to AUD 17.71 during the past year
      What is the PE ratio of Clinuvel Pharmaceuticals?
      The price to earnings ratio of Clinuvel Pharmaceuticals is 16.1
      What is the cash to sales ratio of Clinuvel Pharmaceuticals?
      The cash to sales ratio of Clinuvel Pharmaceuticals is 6.46
      What is the reporting currency for Clinuvel Pharmaceuticals?
      Clinuvel Pharmaceuticals reports financial results in AUD
      What is the latest annual turnover for Clinuvel Pharmaceuticals?
      The latest annual turnover of Clinuvel Pharmaceuticals is AUD 88.74M
      What is the latest annual profit for Clinuvel Pharmaceuticals?
      The latest annual profit of Clinuvel Pharmaceuticals is AUD 35.64M
      What is the registered address of Clinuvel Pharmaceuticals?
      The registered address for Clinuvel Pharmaceuticals is LEVEL 11, 535 BOURKE STREET, MELBOURNE, VICTORIA, 3000
      What is the Clinuvel Pharmaceuticals website address?
      The website address for Clinuvel Pharmaceuticals is www.clinuvel.com
      Which industry sector does Clinuvel Pharmaceuticals operate in?
      Clinuvel Pharmaceuticals operates in the DRUGS-HEALTH R&D/TESTING LABS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KALKalgoorlie Gold Mining Ltd
      AUD 0.086
      (273.91%)
      		100.5M
      E79E79 Gold Mines Ltd
      AUD 0.038
      (100.00%)
      		14.68M
      SLZOSultan Resources Ltd
      AUD 0.002
      (100.00%)
      		335.71k
      TMSOTennant Minerals Ltd
      AUD 0.002
      (100.00%)
      		500k
      BP8BPH Global Ltd
      AUD 0.003
      (50.00%)
      		1.45M
      NACONAOS Ex50 Opportunities Company Limited
      AUD 0.001
      (-50.00%)
      		31.7k
      ADNOCAndromeda Metals Limited
      AUD 0.001
      (-50.00%)
      		750k
      VPRVolt Group Ltd
      AUD 0.001
      (-50.00%)
      		300.11k
      EELENRG Elements Ltd
      AUD 0.001
      (-50.00%)
      		1.05M
      UNTOAUnith Ltd
      AUD 0.003
      (-40.00%)
      		50k
      1TTThrive Tribe Technologies Ltd
      AUD 0.002
      (-33.33%)
      		145.77M
      KALKalgoorlie Gold Mining Ltd
      AUD 0.086
      (273.91%)
      		100.5M
      SYASayona Mining Limited
      AUD 0.025
      (2.04%)
      		98.07M
      MYRMyer Holdings Limited
      AUD 0.89
      (5.33%)
      		65.63M
      POSPoseidon Nickel Limited
      AUD 0.0055
      (22.22%)
      		57.15M

      Discussion

      View Full Feed
      Bull_Dolphin Bull_Dolphin 4 minutes ago
      Yeah, me too!

      I'm a skeptic as to the latter.
      Fully Diluted Fully Diluted 6 minutes ago
      Hi kthomp19,

      It's sad to see that the quality of your posts has gone way down. That's also the reason why I haven't responded to your previous replies to my posts, too bad. 😢

      Now you don't even seem to know what market cap means anymore. Or how else can you expl
      FNMA
      madtrader2132 madtrader2132 6 minutes ago
      RAFA
      TJG TJG 6 minutes ago
      That's not really true. Convertible debt is handled thru the Transfer Agent. The debt itself has terms attached. First term is the length of restriction, most often it's 6 months but can be a year 

      Second term is interest attached to the money given the company for the shares plus a d
      AFFU
      madtrader2132 madtrader2132 7 minutes ago
      RAFA
      ksquared ksquared 7 minutes ago
      Morning, Bull. It's obvious it's uninhabitable.
      The solution sounds good in theory. As long as we don't wind up stuck with the Palestinians and the Middle East denizens finance it... have at it.
      Good luck rebuilding Gaza and good luck keeping it sound.
      I'm a ske
      NoScaredMoneyHere NoScaredMoneyHere 8 minutes ago
      Whoa whoa. No need for name calling bro. So angry. Im so glad you’re here looking out for us. Do you only give financial advice or personal too? You sir.. keep up the good work👏.
      GRLF
      weedtrader420 weedtrader420 9 minutes ago
      CGC Earnings today
      WEED
      StonkMaster StonkMaster 10 minutes ago
      In all fairness, an approval in mid-end March is still in line with assessment timelines over the past year or so. I've always thought that the clock started on the 2nd validation date of March 7, 2024, so if we get approval let's say March 27, 2025, that would be 385 days. Subtract the standard 60
      NWBO
      Hi_Lo Hi_Lo 12 minutes ago
      He/she was on another defunct ticker that GS allegedly was going to take over from a homeless man that was leaving on streets, hijacking of that shell fell apart, so he/she is disgruntled past shareholder that couldn't score.
      If that's the case then why am I long WNFT for more than three year
      GVSI OTCM WNFT
      ksquared ksquared 15 minutes ago
      Illegal border crossings have plummeted 90% since Trump returned to White House, Border Patrol chief says
      By Jennie Taer and Chris Nesi Published Feb. 6, 2025, 4:55 p.m. ET

      The new US Border Patrol chief said the number of illegal migrants stopped trying to cross the besieged
      ksquared ksquared 15 minutes ago
      That didn't take long...
      https://nypost.com/wp-content/uploads/sites/2/2025/02/FEBRUARY07.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
      weedtrader420 weedtrader420 18 minutes ago
      CGC AI Stewart YEAR OF THE CAT ☝️😮‍💨✌️🦨🌳
      WEED
      dmb2 dmb2 18 minutes ago
      Completely understand and agree, I just shake my head, take a breath and envision a tush push from the 1 yd line for approval in March. We seem to get penalized a lot and just keep moving forward play after play.

      GLTA
      NWBO
      Penny Stocks 2.0 Penny Stocks 2.0 18 minutes ago
      Huge post, solid DD. People who sold yesterday and or took a profit, might have some regrets. Regardless, let's keep the DD coming, Huge opportunity with this low Floater. 

      (PS not knocking anyone for taking a profit.)
      HADV
      gbb777 gbb777 19 minutes ago
      Is that recoil kit prototype a failure? The market has lost confidence. 
      VTSI
      Money hunt Money hunt 25 minutes ago
      Goodmorning peeps, this is your captain speaking , fasten up your seatbelts and embrace yourselves for worldwide cancer cure impact
      RNAZ
      bernice bernice 25 minutes ago
      Dream over ??
      What ?
      I see 19 % green in Germany at LS Exchange, lol.
      This is enough for dreaming.

      NB
      uranium-pinto-beans uranium-pinto-beans 25 minutes ago
      AFRM
      Affirm price target raised to $85 from $78 at JMP Securities
      JMP Securities analyst David Scharf raised the firm's price target on Affirm to $85 from $78 and keeps an Outperform rating on the shares. Affirm reported significantly better than expected Q2 results, and the updated
      KS46268 KS46268 26 minutes ago
      FORM 7
      MONTHLY PROGRESS REPORT
      Name of Listed Issuer: Two Hands Corporation (the “Issuer”)
      Trading Symbol: TWOH
      Number of Outstanding Listed Securities: 5,469,037,729
      Date: February 6, 2025
      This Monthly Progress Report must be posted before the openin
      TWOH
      BurgerKing82 BurgerKing82 26 minutes ago
      Could go back up eventually?
      QGSI
      sctts sctts 26 minutes ago
      $$$ Today is the Day $$$$

      $$$$ $FRX $$$
      FRX
      weedtrader420 weedtrader420 28 minutes ago
      ☝️😮‍💨✌️XRP 🐳 Weak hands, fear and greed is at 35 pretty low Morning Has Broken
      XRPUSD
      DiamondHealer95 DiamondHealer95 28 minutes ago
      We're currently at 10 cents according to Yahoo. It's been an odd climb this week albeit a penny. Will the next big thing buy more shares dump from beacham come today for his 1 cent gains or is this a true calm before the storm and I'm wrong about their pattern of behavior. I hope I'm wrong.
      KBLB
      uranium-pinto-beans uranium-pinto-beans 29 minutes ago
      Apple’s China Focus Thrusts It Into Center of Geopolitical Fight

      Your Recent History

      ASX
      CUV
      Clinuvel Pharmaceuticals
      DOWI
      DWEUBS
      DJ Europe Basic Material...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads